đź’¨ Abstract
Novo Nordisk A/S, maker of the weight loss drug Wegovy, announced that its CEO, Lars Fruergaard Jorgensen, is stepping down due to recent market challenges and a 50% decline in share price since mid-2024. This comes after the company downgraded its sales and profit forecasts, partly due to competition from cheaper replica drugs and a study showing a competitor’s drug, Zepbound, was more effective.
Courtesy: wtop.com
Suggested
The US indicts a Mexican citizen on terrorism charges for helping cartel -
The Warriors view midseason addition of Jimmy Butler as a big move for next season -
1 person died and 2 others were pulled from wreckage after a severe storm crumbled part of a St. Louis church -
Argentina suspende importaciĂłn de productos de origen aviar de Brasil tras brote de influenza en granja de Rio Grande do Sul -
El optimismo de los estadounidenses respecto a la economĂa se encuentra en un mĂnimo casi histĂłrico -
Regions Tradition Par Scores -
Regions Tradition Tour Scores -
School newspapers thousands of miles apart team up to heal from wildfires -
In dispute over college roster limits, a trial could loom if judge doesn’t approve latest proposal -
CĂłmo se vota con la Boleta Ăšnica ElectrĂłnica en las elecciones de CABA -